Hepatitis C, Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma, Current Information On Hepatitis C & treatments for the medical professional and patient. | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Hepatitis C, Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma, Current Information On Hepatitis C & treatments for the medical professional and patient.

Transarterial Embolization Versus Symptomatic Treatment in Patients
With Advanced Hepatocellular Carcinoma:
Results of a Randomized, Controlled Trial in a Single Institution

table 3.

Probability of Survival of the Patients According
to Their Baseline Characteristics


Baseline Characteristic Probability of Survival


P
2 yr 4 yr Median (mo)

Child-Pugh’s class A
  TAE (35) 56% 15% 27
  Control (31) 52% 27% 25 0.95
Child-Pugh’s class B
  TAE (5) 0% 0% 7
  Control (9) 44%   13 0.46
Okuda’s stage I
  TAE (27) 59% 15% 28
  Control (27) 56% 31% 26 0.64
Okuda’s stage II
  TAE (13) 27% 13% 13
  Control (13) 38%   13 0.69
Performance status 0 
  TAE (27) 62% 18% 29
  Control (27) 63% 36% 29 0.91
Performance status 1 
  TAE (11) 27% 0% 9
  Control (11) 27%   18 0.67

[Return To Article]